“We hope that our new ability to monitor these sleepy and resistant bacteria in sputum will enable us to treat the disease more quickly,” he added.
“This work has taken more than 10 years to come to fruition and has taken dedicated work from the teams in Leicester and London. I am particularly delighted for my team in Leicester who fought long and hard to bring this story together,” Barer said.
Epaper
Newsletter
Stocks
Weather
Horoscope
